BEIJING -- Researchers from the Institute of Automation at the Chinese Academy of Sciences have revealed the intrinsic ...

D Molecular Therapeutics is undervalued, with its lead candidate 4D-150 showing potential. Click here to find out why I rate ...

The high cost of sickle cell gene therapies is pushing private insurers and Medicaid programs to develop new payment models.

Solid said that the first patients to receive its Duchenne gene therapy all produced high levels of the target protein, an ...

Vincent Gaynor remembers, almost to the minute, when he realized his part in birthing the breakthrough gene therapy Zolgensma ...

In today's Daily Briefing, we tell you how city leaders hope to expand the local economy, how blowing sand is being addressed ...

You may have heard about the large underground seed vault in Svalbard, Norway, which opened in 2008. But you might be ...

Voters will choose between Decker and Schwab when they cast their ballots in the Feb. 25 Democratic primary to determine not only their party’s nominee but the city’s treasurer.

Pfizer terminated partnership with Sangamo on hemophilia A gene therapy despite positive Phase 3 data. Find out why SGMO ...

"We’re not developing gene-edited plants, and genetic modification is not on our roadmap," CEO Brad Zamft tells TechCrunch. For now, the startup focuses on using AI analysis to identify optimal ...

Bharat Kakade, the president and managing trustee of Pune- based BAIF Development Research Foundation, popularly known as BAIF, welcomed Union Finance Minister Nirmala Sitharaman’s announcement of ...

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.) ...